These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12745120)

  • 1. Prognostic implication of troponin I elevation after percutaneous coronary intervention.
    Nallamothu BK; Chetcuti S; Mukherjee D; Grossman PM; Kline-Rogers E; Werns SW; Bates ER; Moscucci M
    Am J Cardiol; 2003 May; 91(10):1272-4. PubMed ID: 12745120
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.
    Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R
    Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
    Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
    J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of cardiac marker elevation after percutaneous coronary intervention.
    Nageh T; Sherwood RA; Thomas MR
    Circulation; 2002 Mar; 105(12):e73. PubMed ID: 11914268
    [No Abstract]   [Full Text] [Related]  

  • 5. Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
    Stadius ML
    J Am Coll Cardiol; 2004 Jul; 44(1):25-7. PubMed ID: 15234400
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
    Sharma SK; Choudhury A; Lee J; Kim MC; Fisher E; Steinheimer AM; Kini AS
    Am J Cardiol; 2004 Oct; 94(7):913-7. PubMed ID: 15464676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
    Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
    Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction.
    Giannitsis E; Müller-Bardorff M; Lehrke S; Wiegand U; Tölg R; Weidtmann B; Hartmann F; Richardt G; Katus HA
    Circulation; 2001 Aug; 104(6):630-5. PubMed ID: 11489766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery.
    Holmvang L; Jurlander B; Rasmussen C; Thiis JJ; Grande P; Clemmensen P
    Chest; 2002 Jan; 121(1):103-11. PubMed ID: 11796438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
    Natarajan MK; Kreatsoulas C; Velianou JL; Mehta SR; Pericak D; Goodhart DM
    Am J Cardiol; 2004 Mar; 93(6):750-3. PubMed ID: 15019884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of angiographically significant stenosis in patients with chest pain and an elevated troponin I level and normal creatine kinase and creatine kinase-MB levels.
    Almeda FQ; Calvin JE; Parrillo JE; Sun FG; Barron JT
    Am J Cardiol; 2001 Jun; 87(11):1286-9. PubMed ID: 11377357
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.
    Ricciardi MJ; Wu E; Davidson CJ; Choi KM; Klocke FJ; Bonow RO; Judd RM; Kim RJ
    Circulation; 2001 Jun; 103(23):2780-3. PubMed ID: 11401931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.